{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1363670319510230400.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1016/j.imlet.2017.07.015"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0165247817301761?httpAccept=text/xml"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0165247817301761?httpAccept=text/plain"}}],"dc:title":[{"@value":"Nanoparticles and targeted drug delivery in cancer therapy"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1383670319510230404","@type":"Researcher","foaf:name":[{"@value":"Behdokht Bahrami"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670319510230403","@type":"Researcher","foaf:name":[{"@value":"Mohammad Hojjat-Farsangi"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670319510230406","@type":"Researcher","foaf:name":[{"@value":"Hamed Mohammadi"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670319510230401","@type":"Researcher","foaf:name":[{"@value":"Enayat Anvari"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670319510230405","@type":"Researcher","foaf:name":[{"@value":"Ghasem Ghalamfarsa"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670319510230402","@type":"Researcher","foaf:name":[{"@value":"Mehdi Yousefi"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670319510230400","@type":"Researcher","foaf:name":[{"@value":"Farhad Jadidi-Niaragh"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"01652478"}],"prism:publicationName":[{"@value":"Immunology Letters"}],"dc:publisher":[{"@value":"Elsevier BV"}],"prism:publicationDate":"2017-10","prism:volume":"190","prism:startingPage":"64","prism:endingPage":"83"},"reviewed":"false","dc:rights":["https://www.elsevier.com/tdm/userlicense/1.0/"],"url":[{"@id":"https://api.elsevier.com/content/article/PII:S0165247817301761?httpAccept=text/xml"},{"@id":"https://api.elsevier.com/content/article/PII:S0165247817301761?httpAccept=text/plain"}],"createdAt":"2017-07-29","modifiedAt":"2025-06-24","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360294643858867072","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Metal Oxide Engineered Nanomaterials Modulate Rabbit Corneal Fibroblast to Myofibroblast Transformation"}]},{"@id":"https://cir.nii.ac.jp/crid/1360302866859927552","@type":"Article","resourceType":"preprint","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Neodymium-Doped Nanocrystals for Diffraction-limited\n                  <i>in vitro</i>\n                  Temperature Sensing"}]},{"@id":"https://cir.nii.ac.jp/crid/1360851950124794368","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Serum Albumin-treated SN-38 Prodrug Nanoparticles toward Cancer Treatment"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1016/j.imlet.2017.07.015"},{"@type":"CROSSREF","@value":"10.1167/tvst.10.12.23_references_DOI_BPwzqJ7o7ddGsC8sLDRDNAXDigB"},{"@type":"CROSSREF","@value":"10.1101/2024.02.08.579538_references_DOI_BPwzqJ7o7ddGsC8sLDRDNAXDigB"},{"@type":"CROSSREF","@value":"10.1246/cl.210253_references_DOI_BPwzqJ7o7ddGsC8sLDRDNAXDigB"}]}